Fulminant Myocarditis Following SARS-CoV-2 Infection JACC Patient Care Pathways

A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy. (C) 2022 by the American College of Cardiology Foundation.

Automated summary

A 60-year-old woman with a history of asthma developed fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. She had a complicated hospital course but ultimately recovered and was discharged with normal left ventricular systolic function. However, she later developed symptomatic ventricular tachycardia and received treatment with an implantable cardioverter-defibrillator and antiarrhythmic drugs.